A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2006
11/16/2006	US20060257329 Delivery of drug esters through an inhalation route
11/16/2006	US20060257326 Methods and formulations for delivery of pharmacologically active agents
11/16/2006	DE59207523C5 Prepn. of compsn. contg. human protein and pharmaceuticals for infusion - contains preservatives which are opt. removed before storage, for germ free prod. giving minimal pain upon application
11/16/2006	DE102005011988A1 Die vorliegende Erfindung betrifft die Verwendung von Keratin-bindenden Polypeptiden und ihre Herstellung The present invention relates to the use of keratin-binding polypeptides and their preparation
11/16/2006	CA2608086A1 Strategies for delivery of active agents using micelles and particles
11/16/2006	CA2607977A1 Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds
11/16/2006	CA2607954A1 Conjugate for targeting of drug
11/16/2006	CA2607912A1 Medical composition for promotion of skin regeneration
11/16/2006	CA2607229A1 Isoalkane mixture, its preparation and use
11/16/2006	CA2607181A1 A non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
11/16/2006	CA2606598A1 Pharmaceutical formulations of hdac inhibitors
11/16/2006	CA2606390A1 Stable lyophilized anthracycline glycosides
11/15/2006	EP1722227A2 Epitopes formed by non-covalent association of conjugates
11/15/2006	EP1721620A1 Directly-compressible xylitol powder
11/15/2006	EP1721619A1 Soft capsule preparation
11/15/2006	EP1721610A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
11/15/2006	EP1721606A2 Buffered compositions for dialysis
11/15/2006	EP1721604A1 Stable capsule preparation
11/15/2006	EP1720996A1 Fusion proteins containing recombinant cytotoxic rnases
11/15/2006	EP1720906A2 Antibody compositions and methods
11/15/2006	EP1720579A1 Galactomannans and/or glucomannans for increasing the bioavailability of active substances
11/15/2006	EP1720578A2 Bacteriostatic esters for topical use
11/15/2006	EP1720575A2 Therapeutic and diagnostic conjugates for use with multispecific antibodies
11/15/2006	EP1720534A1 Method and composition for burned skin
11/15/2006	EP1720533A2 Amoxicillin instant granulate
11/15/2006	EP1720532A1 Controlled release formulations
11/15/2006	EP1720529A2 Kit comprising a plaster that optionally contains an active ingredient and an agent that prevents skin irritation
11/15/2006	EP1720526A1 Coated conditioners for use in foods and pharmaceuticals
11/15/2006	EP1720525A1 Powdered compositions of sensitive active materials in an at least partially amorphous state
11/15/2006	EP1720522A1 Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, dna vaccination and administration of gene based drugs
11/15/2006	EP1720518A1 Alginate viscoelastic composition, method of use and package
11/15/2006	EP1720410A1 Compositions and methods for the treatment and clinical remission of psoriasis
11/15/2006	EP1633334B1 Topical administration of vasoactive vitamin b3 compounds for promoting sleep
11/15/2006	EP1545994B1 Injectable pharmaceutical suspension in a two-chamber vial
11/15/2006	EP1492417B1 Encapsulated agglomeration of microcapsules and method for the preparation thereof
11/15/2006	EP1389092B1 Abuse-resistant opioid dosage form
11/15/2006	EP1353968B1 Linear block copolymer
11/15/2006	EP1315479B1 Pectin film compositions
11/15/2006	EP1254659B1 Stable emulsion compositions
11/15/2006	EP1204627B1 Process for producing branched, largely unsaturated fatty alcohol polyglycolethers
11/15/2006	EP1105107B1 Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
11/15/2006	EP1042388B1 Polyhydroxyalkanoate compositions having controlled degradation rates
11/15/2006	EP1039921B1 Substantially pure histidine-linked protein polymer conjugates
11/15/2006	EP1009430B1 Oil in water emulsion vaccines against Hepatitis B
11/15/2006	EP0873127B1 Anthelmintic macrocyclic lactone compositions
11/15/2006	CN1863921A Methods for expression and purification of immunotoxins
11/15/2006	CN1863866A Finely particulate composite containing carbon compound encapsulated therein
11/15/2006	CN1863734A Highly oil absorbing amorphous silica particles
11/15/2006	CN1863562A Pressure-sensitive adhesive sheet for application to skin
11/15/2006	CN1863560A Fibrinogen targetting microparticles for promoting haemostasie
11/15/2006	CN1863559A 化合物 Compound
11/15/2006	CN1863558A Polyarginine-modified liposome capable of transferring into nucleus
11/15/2006	CN1863557A In-situ gelling drug delivery system
11/15/2006	CN1863554A Process for preparing polysaccharide-protein conjugate vaccines
11/15/2006	CN1863553A Process for preparing polysaccharide-protein conjugate vaccines
11/15/2006	CN1863549A Conjugates of a polymer and a protein linked by an oxime linking group
11/15/2006	CN1863535A Noncrystalline antibacterial composition containing cefditoren pivoxil
11/15/2006	CN1863516A Multilayer dosage form comprising a matrix that influences release of a modulatory substance
11/15/2006	CN1863510A Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
11/15/2006	CN1863508A Target-directed and enteric absorption-controlled liposome having sugar chain and cancer remedy and diagnostic containing the same
11/15/2006	CN1863507A Remedy or diagnostic for inflammatory disease containing target-directing liposome
11/15/2006	CN1863505A Novel liquid preparation composition
11/15/2006	CN1861193A Kidney target precursor medicine, said prepn., its preparing method and application
11/15/2006	CN1861192A Camptothecin type medicine loaded on high molecular nano-microsphere, and its prepn. method
11/15/2006	CN1861095A Load type super-fine copper-powder copper-complementary agent, its prepn. method and use
11/15/2006	CN1861091A Load type molecular iodine complementary agent, and its prepn. method and use
11/15/2006	CN1861086A Pirarubicin emulsion composition
11/15/2006	CN1861084A Compound fluorophenylnico injection, prepn. method and use thereof
11/15/2006	CN1861082A Medicine prepn. of compounding deoxypregnene contg. non-ionic surfactant
11/15/2006	CN1861059A Hydrophilic gel type percutaneous plaster contg. capsaicin, and its prepn. method
11/15/2006	CN1861058A Micro-capsule soybean isoflavone and its prepn. method
11/15/2006	CN1861057A Soft capsule contg. lecithin complex iodine and its prepn. method
11/15/2006	CN1861055A Composite slow-releasing anticarcinogen injection contg. platinum compounds
11/15/2006	CN1861054A Composite slow-releasing anticarcinogen contg. platinum compounds such as sunpla
11/15/2006	CN1861053A Slow-releasing injection contg. platinum compounds and cytotoxin type anticarcinogen
11/15/2006	CN1861052A Slow-releasing injection contg. platinum compound and cytotoxin type anticarcinogen
11/15/2006	CN1861051A Slow-releasing injection contg. platinum compounds and its potentiator type anticarcinogen
11/15/2006	CN1861050A Slow-releasing injection contg. platinum compounds and its potentiator type anticarcinogen
11/15/2006	CN1861049A Slow-releasing injection contg anticarcinogen of Jixitabin
11/15/2006	CN1861048A Slow-releasing injection contg. vasoinhibitor and cytotoxin type anticarcinogen
11/15/2006	CN1861047A Slow-releasing injection contg. vasoinhibitor and potentiator type anticarcinogen
11/15/2006	CN1861044A Voriconazole injection and its prepn. method
11/15/2006	CN1861043A Ximite acid injection for anti-tumor and its prepn. method
11/15/2006	CN1861041A Temp-sensitive, slow-releasing gel used for local injection, and its prepn. method
11/15/2006	CN1284801C Biodegradable hyaluronic acid derivative, biodegradable polymeric micelle composition and pharmaceutical composition
11/15/2006	CN1284786C Glycyrrhetic acid and phospholipid composites of glycyrrhetate and process for preparing same
11/15/2006	CN1284664C Device for manufacturing dosage forms
11/15/2006	CN1284603C Heterobifunctional poly(ethylene Glycol) derivatives and methods for their preparation
11/15/2006	CN1284601C Vaccine composition stable at normal temperature and its preparation
11/15/2006	CN1284533C Use of an acetylated pre-gelled starch with a high content of amylose
11/15/2006	CN1284532C Cored molded article undergoing quick disintegration
11/15/2006	CN1284524C Application of solid liposome nanoparticle for preparing pharmaceutical used for ion leading-in trandermal therapy
11/15/2006	CN1284523C Method of coating fine particle with lipid film
11/15/2006	CN1284522C Dextrose and insulin fluid formulation for intravenous infusion
11/14/2006	US7135549 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
11/14/2006	US7135547 Peptide conjugated anti-cancer prodrugs
11/14/2006	US7135496 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases
11/14/2006	US7135465 Sustained release beadlets containing stavudine
11/14/2006	US7135464 Method of administering decitabine
11/14/2006	US7135338 Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism

1 ... 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 ... 1712